BACKGROUND: Atrial refractoriness may be an important determinant of atrial fibrillation (AF) risk, but its measurement is not clinically accessible. Because the QT interval predicts incident AF and the atrium and ventricle share repolarizing ion currents, we investigated the association between an individual's QT interval and atrial effective refractory period (AERP). METHODS: In paroxysmal AF patients presenting for catheter ablation, the QT interval was measured from the surface 12-lead electrocardiogram. The AERP was defined as the longest S1-S2 coupling interval without atrial capture using a 600-ms drive cycle length. RESULTS: In 28 patients, there was a positive correlation between QTc and mean AERP. After multivariate adjustment, a 1-ms increase in QTc predicted a 0.70-ms increase in AERP. CONCLUSIONS: The QTc interval reflects the AERP, suggesting that the QTc interval may be used as a marker of atrial refractoriness relevant to assessing AF risk and mechanism-specific therapeutic strategies.
BACKGROUND:Atrial refractoriness may be an important determinant of atrial fibrillation (AF) risk, but its measurement is not clinically accessible. Because the QT interval predicts incident AF and the atrium and ventricle share repolarizing ion currents, we investigated the association between an individual's QT interval and atrial effective refractory period (AERP). METHODS: In paroxysmal AFpatients presenting for catheter ablation, the QT interval was measured from the surface 12-lead electrocardiogram. The AERP was defined as the longest S1-S2 coupling interval without atrial capture using a 600-ms drive cycle length. RESULTS: In 28 patients, there was a positive correlation between QTc and mean AERP. After multivariate adjustment, a 1-ms increase in QTc predicted a 0.70-ms increase in AERP. CONCLUSIONS: The QTc interval reflects the AERP, suggesting that the QTc interval may be used as a marker of atrial refractoriness relevant to assessing AF risk and mechanism-specific therapeutic strategies.
Authors: Pentti M Rautaharju; Borys Surawicz; Leonard S Gettes; James J Bailey; Rory Childers; Barbara J Deal; Anton Gorgels; E William Hancock; Mark Josephson; Paul Kligfield; Jan A Kors; Peter Macfarlane; Jay W Mason; David M Mirvis; Peter Okin; Olle Pahlm; Gerard van Herpen; Galen S Wagner; Hein Wellens Journal: Circulation Date: 2009-02-19 Impact factor: 29.690
Authors: Samuel Sossalla; Birte Kallmeyer; Stefan Wagner; Marek Mazur; Ulrike Maurer; Karl Toischer; Jan D Schmitto; Ralf Seipelt; Friedrich A Schöndube; Gerd Hasenfuss; Luiz Belardinelli; Lars S Maier Journal: J Am Coll Cardiol Date: 2010-05-25 Impact factor: 24.094
Authors: Mala C Mandyam; Elsayed Z Soliman; Alvaro Alonso; Thomas A Dewland; Susan R Heckbert; Eric Vittinghoff; Steven R Cummings; Patrick T Ellinor; Bernard R Chaitman; Karen Stocke; William B Applegate; Dan E Arking; Javed Butler; Laura R Loehr; Jared W Magnani; Rachel A Murphy; Suzanne Satterfield; Anne B Newman; Gregory M Marcus Journal: Heart Rhythm Date: 2013-07-18 Impact factor: 6.343
Authors: David M German; Muammar M Kabir; Thomas A Dewland; Charles A Henrikson; Larisa G Tereshchenko Journal: Ann Noninvasive Electrocardiol Date: 2015-11-02 Impact factor: 1.468
Authors: Kurt Vanhoutte; Carlo de Asmundis; Anna Francesconi; Jurgen Figysl; Griet Steurs; Tim Boussy; Markus Roos; Andreas Mueller; Lucio Massimo; Gaetano Paparella; Kristien Van Caelenberg; Gian Battista Chierchia; Andrea Sarkozy; Pedro Brugada Y Terradellas; Martin Zizi Journal: Bioinformation Date: 2009-01-12